Awakn Life Sciences Corp.

CNSX:AWKN Stock Report

Market Cap: CA$7.7m

Awakn Life Sciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Anthony Tennyson

Chief executive officer

CA$311.4k

Total compensation

CEO salary percentage77.1%
CEO tenure3.9yrs
CEO ownership5.1%
Management average tenureno data
Board average tenure2.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Anthony Tennyson's remuneration changed compared to Awakn Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Oct 31 2023n/an/a

-CA$7m

Jul 31 2023n/an/a

-CA$8m

Apr 30 2023n/an/a

-CA$8m

Jan 31 2023CA$311kCA$240k

-CA$9m

Oct 31 2022n/an/a

-CA$8m

Jul 31 2022n/an/a

-CA$10m

Apr 30 2022n/an/a

-CA$18m

Jan 31 2022CA$348kCA$220k

-CA$16m

Oct 31 2021n/an/a

-CA$13m

Jan 31 2021CA$72kCA$52k

-CA$1m

Compensation vs Market: Anthony's total compensation ($USD226.71K) is about average for companies of similar size in the Canadian market ($USD175.58K).

Compensation vs Earnings: Anthony's compensation has been consistent with company performance over the past year.

CEO

Anthony Tennyson

3.9yrs

Tenure

CA$311,400

Compensation

Mr. Anthony Tennyson is a Co-founder and has been President & Chief Executive Officer of Awakn Life Sciences Corp. since June 1, 2020 and has been its Director since May 21, 2020. Mr. Tennyson serves as Ex...

Board Members

NamePositionTenureCompensationOwnership
George Scorsis
Co-founder & Chairman of the Board4yrsCA$34.26k2.86%
CA$ 220.5k
Anthony Tennyson
Co-founder4yrsCA$311.40k5.12%
CA$ 394.4k
David Nutt
Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer2.9yrsno data0.35%
CA$ 27.3k
Barbara Mason
Member of Clinical Advisory Board2.8yrsno datano data
Shaun McNulty
Member of Pre-Clinical Advisory Board2.8yrsCA$241.21kno data
Stephen Page
Independent Non Executive Director3.1yrsCA$18.76k0.17%
CA$ 13.3k
John Papastergiou
Independent Non Executive Director3.1yrsCA$18.76k0.099%
CA$ 7.7k
Ann Mithoefer
Member of Clinical Advisory Board3.7yrsno datano data
Michael Mithoefer
Member of Clinical Advisory Boardno datano datano data
Kevin Fone
Member of Pre-Clinical Advisory Board2.8yrsno datano data
Harriet de Wit
Member of Pre-Clinical Advisory Board2.8yrsno datano data
Stephen Husbands
Member of Pre-Clinical Advisory Board2.8yrsno datano data

2.9yrs

Average Tenure

Experienced Board: AWKN's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.